I decided in RAD because it has more short term potential for share price movement due to the faster to market diagnostics. It also has the longer term therapeutic valuation potential as clinical trial data starts to come in, but this won't happen anytime soon due to the much longer development cycle. The dual approach decreases risk somewhat as diagnostics are less risky than therapeutics in terms of potential for failure. I also like the radiotherapy approach in general.
I decided in RAD because it has more short term potential for...
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.001(2.50%) |
Mkt cap ! $18.52M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.3¢ | 4.0¢ | $15.02K | 367.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 75641 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 114 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.0¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.1¢ | 4.3¢ | 4.0¢ | 131648 | ||
| Last updated 15.54pm 06/05/2024 ? | |||||
| RAD (ASX) Chart |